Better quality of life
During
a crowded and elegant event on December 05, in the city
of Mogi das Cruzes, pharmexx Brazil received the certificate
and the social certification label for cooperating with
the social projects developed by the institution. The
Social Action Department director of pharmexx Brazil,
Angélica Leone Rossetti, highlighted during the
event that the companies need to continuously develop
actions in order to help the community and provide them
a better quality of life.
Terra Institute was founded in 2002 and
throughout those five years has carried out over fifty
projects, like “If this street was mine”,
which benefited 600 people. To read more about the institute,
click
here
  
|
Prostate cancer
Zodiac brought to Brazil Eligard 22.5mg, a medicine
that intends to reduce the production of testosterone. According
to data from the National Cancer Institute (INCA), it is estimated
that in 2006, 47 thousand new cases of the diseases were registered,
what means a risk of 51 new cases for every 100 thousand inhabitants.
International
The commercial manager of pharmexx Brazil, Elilson Anthonio, represented the company at the official launch of pharmexx Argentina, which had the presence of the general manager of pharmexx, Michael Schomaker, and further 50 executives. Antonio made a presentation on the Brazilian subsidiary, highlighting success cases.
Treatment for Obesity I
Biosintética Biogenerics bet on the treatment
of obesity and they have recently introduced a medicine based
on Sibutramine Hydrochloride Monohydrate, which is available in
10mg and 15mg, 30-capsule canisters packages.
Treatment for Obesity II
Eurofarma released on the market the generic Sibutramine
Hydochloride, which reference medicine is Reductil, by Abbott.
“With this launch, Eurofarma introduces to physicians and
consumers the new generic option and the proposal of quality with
economy, by providing a treatment at a very reasonable price”,
says Maria Del Pilar Muñoz, the Corporate Marketing director
of Eurofarma.
Nervous System
Medley has recently launched on the market two
medicines for the treatment of diseases linked to the nervous
system. Alzepinol, with 20 pills and dosage options (300 mg and
600 mg) and Alenthus, with 15 controlled-release capsules with
75 mg or 150 mg.